All News #Library
Biotech
Stemcyte Launches FDA-Cleared Regenecyte Program For Long COVID
26 Jan 2026 //
PR NEWSWIRE BIO
StemCyte Announces Positive Ph IIa Results for Post-COVID Syndrome
19 Dec 2024 //
PR NEWSWIRE

Market Place
Sourcing Support